SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference
SOPHiA GENETICS (SOPH), a cloud-native software company specializing in data-driven medicine, has announced its participation in two major healthcare conferences in September 2024. Ross Muken, the company's CFO and COO, will present at the 22nd Annual Morgan Stanley Healthcare Conference on September 4 at 1:50 p.m. EDT in New York City.
The following week, Dr. Jurgi Camblong, co-Founder and CEO, will join a panel discussion on AI in Healthcare at the 9th Annual TD Cowen FutureHealth Conference on September 10 at 3:15 p.m. EDT, also in New York City. Both presentations will be webcast live on the SOPHiA GENETICS Investor Relations website, with replays available after the events.
SOPHiA GENETICS (SOPH), una azienda software nativa nel cloud specializzata in medicina basata sui dati, ha annunciato la sua partecipazione a due importanti conferenze sanitarie a settembre 2024. Ross Muken, CFO e COO dell'azienda, presenterà alla 22ª Conferenza Annuale sulla Salute di Morgan Stanley il 4 settembre alle 13:50 EDT a New York City.
La settimana successiva, Dr. Jurgi Camblong, co-fondatore e CEO, parteciperà a una discussione di panel su AI nella Sanità durante la 9ª Conferenza Annuale FutureHealth di TD Cowen il 10 settembre alle 15:15 EDT, sempre a New York City. Entrambe le presentazioni saranno trasmesse in diretta sul sito delle Relazioni con gli Investitori di SOPHiA GENETICS, con la possibilità di rivederle dopo gli eventi.
SOPHiA GENETICS (SOPH), una empresa de software nativa en la nube especializada en medicina basada en datos, ha anunciado su participación en dos importantes conferencias de salud en septiembre de 2024. Ross Muken, CFO y COO de la empresa, presentará en la 22ª Conferencia Anual de Salud de Morgan Stanley el 4 de septiembre a la 1:50 p.m. EDT en la ciudad de Nueva York.
La semana siguiente, Dr. Jurgi Camblong, cofundador y CEO, participará en una discusión de panel sobre IA en la Salud en la 9ª Conferencia Anual FutureHealth de TD Cowen el 10 de septiembre a las 3:15 p.m. EDT, también en la ciudad de Nueva York. Ambas presentaciones se transmitirán en vivo en el sitio web de Relaciones con Inversores de SOPHiA GENETICS, con repeticiones disponibles después de los eventos.
SOPHiA GENETICS (SOPH)는 데이터 기반 의료 전문 클라우드 네이티브 소프트웨어 회사로, 2024년 9월에 열리는 두 개의 주요 의료 컨퍼런스에 참여한다고 발표했습니다. Ross Muken 회사의 CFO 겸 COO가 9월 4일 오후 1시 50분 EDT에 뉴욕시에서 제22회 모건 스탠리 헬스케어 컨퍼런스에서 발표할 예정입니다.
SOPHiA GENETICS (SOPH), une entreprise de logiciels native du cloud spécialisée dans la médecine basée sur les données, a annoncé sa participation à deux importantes conférences de santé en septembre 2024. Ross Muken, CFO et COO de l'entreprise, présentera à la 22e Conférence Annuelle sur la Santé de Morgan Stanley le 4 septembre à 13h50 EDT à New York.
La semaine suivante, Dr. Jurgi Camblong, co-fondateur et CEO, participera à une discussion en panel sur l'IA dans la Santé lors de la 9e Conférence Annuelle FutureHealth de TD Cowen le 10 septembre à 15h15 EDT, également à New York. Les deux présentations seront diffusées en direct sur le site des Relations Investisseurs de SOPHiA GENETICS, avec des rediffusions disponibles après les événements.
SOPHiA GENETICS (SOPH), ein cloud-native Softwareunternehmen, das auf datengestützte Medizin spezialisiert ist, hat seine Teilnahme an zwei wichtigen Gesundheitskonferenzen im September 2024 bekannt gegeben. Ross Muken, CFO und COO des Unternehmens, wird am 4. September um 13:50 Uhr EDT in New York City auf der 22. jährlichen Morgan Stanley Gesundheitskonferenz präsentieren.
In der darauf folgenden Woche wird Dr. Jurgi Camblong, Mitgründer und CEO, an einer Podiumsdiskussion zum Thema KI im Gesundheitswesen auf der 9. jährlichen TD Cowen FutureHealth Konferenz am 10. September um 15:15 Uhr EDT ebenfalls in New York City teilnehmen. Beide Präsentationen werden live auf der Investor Relations-Website von SOPHiA GENETICS übertragen, mit der Möglichkeit, sie nach den Veranstaltungen erneut anzusehen.
- None.
- None.
Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 22nd Annual Morgan Stanley Healthcare Conference in
The following week, co-Founder and Chief Executive Officer, Dr. Jurgi Camblong, will join a Panel Discussion on AI in Healthcare at the 9th Annual TD Cowen FutureHealth Conference in
The presentations will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.
View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-present-at-the-22nd-annual-morgan-stanley-healthcare-conference-and-9th-annual-td-cowen-futurehealth-conference-302233232.html
SOURCE SOPHiA GENETICS
FAQ
When is SOPHiA GENETICS presenting at the Morgan Stanley Healthcare Conference in 2024?
Who will represent SOPHiA GENETICS at the Morgan Stanley Healthcare Conference?
What event is SOPHiA GENETICS participating in on September 10, 2024?
Can investors watch SOPHiA GENETICS' presentations at these healthcare conferences?
